MedTrace Logo

Construction of Early Warning Model for the New Psychoactive Substances Using in Adolescents

NCT05958641 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-07-24

No results posted yet for this study

Summary

Based on the biological-psychology-sociological medicine pattern, this study aims to construction an early warning model of the New Psychoactive Substances (NPS) using for adolescents aged 14-35 years old. This study intends to obtain the data related to the behavioral expression of addiction susceptibility genes, adverse childhood experience, cognition, resistance and the use of NPS in adolescents by questionnaire survey (sample size: 200), and then use logistic regression and machine learning to construct an early warning model.

Conditions

  • Drug Addiction

Interventions

OTHER

Questionnaires

Participants will be asked to complete the questionnaire including general demographic information, the cognition, resistance and use of NPS as well as the behavioral expression of addiction susceptibility genes and adverse childhood experience.

Sponsors & Collaborators

  • Wei XIA, PhD

    lead OTHER

Principal Investigators

  • Wei Xia, PhD · Sun Yat-sen University

Eligibility

Min Age
14 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-17
Primary Completion
2023-10-31
Completion
2023-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05958641 on ClinicalTrials.gov